Pignolo, A.; Aprile, M.; Gagliardo, C.; Giammanco, G.M.; D’Amelio, M.; Aridon, P.; La Tona, G.; Salemi, G.; Ragonese, P.
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection. Neurol. Int. 2021, 13, 695-700.
https://doi.org/10.3390/neurolint13040066
AMA Style
Pignolo A, Aprile M, Gagliardo C, Giammanco GM, D’Amelio M, Aridon P, La Tona G, Salemi G, Ragonese P.
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection. Neurology International. 2021; 13(4):695-700.
https://doi.org/10.3390/neurolint13040066
Chicago/Turabian Style
Pignolo, Antonia, Maria Aprile, Cesare Gagliardo, Giovanni Maurizio Giammanco, Marco D’Amelio, Paolo Aridon, Giuseppe La Tona, Giuseppe Salemi, and Paolo Ragonese.
2021. "Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection" Neurology International 13, no. 4: 695-700.
https://doi.org/10.3390/neurolint13040066
APA Style
Pignolo, A., Aprile, M., Gagliardo, C., Giammanco, G. M., D’Amelio, M., Aridon, P., La Tona, G., Salemi, G., & Ragonese, P.
(2021). Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection. Neurology International, 13(4), 695-700.
https://doi.org/10.3390/neurolint13040066